We're proud to share that the @US_FDA has granted accelerated approval for our therapy for advanced melanoma. Learn more: https://lnkd.in/etxeMZUK
Iovance Biotherapeutics, Inc.
Biotechnology Research
San Carlos, California 23,452 followers
Iovance is a patient-centric, collaborative organization that is driven to change the way cancer is treated.
Über uns
Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, that may extend and improve life for patients with cancer. We are adding to our talented team as we execute our commercial launch, advance our research and development efforts, and build our internal manufacturing capabilities. Iovance is headquartered in the San Francisco Bay Area. Our Iovance Cell Therapy Center (iCTC), a state-of-the-art manufacturing facility, is located in Philadelphia. We also have a research site in Tampa, Florida. Any information expressed by Iovance is subject to the risk factors and information on forward-looking statements contained in its filings with the Securities and Exchange Commission and available here: https://ir.iovance.com/sec-filings
- Website
-
http://www.iovance.com/
External link for Iovance Biotherapeutics, Inc.
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 501-1,000 employees
- Hauptsitz
- San Carlos, California
- Typ
- Öffentliches Unternehmen
- Gegründet
- 2007
- Spezialitäten
- Immuno Oncology, Autologous Cell Therapy, Tumor Infiltrating Lymphocytes (TIL), Novel Cancer Immunotherapies, and cell therapy
Standorte
Employees at Iovance Biotherapeutics, Inc.
Aktualisierungen
-
Today Iovance reported second quarter and first half 2024 financial results and corporate updates. We will host an audio webcast at 4:30 pm ET, join live or listen to the replay: https://lnkd.in/e6S3bW7n
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024 | IOVANCE Biotherapeutics, Inc.
ir.iovance.com
-
Thank you Chris Rollins for inspiring a culture of #RippleEffectLeadership. Empathy and single acts of kindness create a powerful #RippleEffect on our daily work and the pursuit of our mission at Iovance!”
The Ripple Effect Leader™ 🌊 | Purpose-Driven Keynote Speaker | 2024 TBBJ Business of Pride Honoree | Building High Trust in a Low-Trust World
Slowing down isn’t about doing less; it’s about focusing on what truly matters. Taking time to share stories, to genuinely see and connect with one another, to listen and build empathy, understanding, and trust... These are some of the foundations of strong teams, strong cultures, and #RippleEffectLeadership. And when you're innovating, developing and delivering life-saving individualized cancer therapies like at Iovance Biotherapeutics, Inc., having a high level of trust is crucial for effective teamwork, communication and collaboration. I'm so grateful that Alyssa Sy, Ashley Gallego and Elizabeth Gonzalez saw me speak in Tampa back in March and believed in the power of #TheRippleEffect. We just wrapped up an amazing day at their site at The Navy Yard in Philadelphia with a private tour of their facility, a talk for their employees and a two-hour workshop with a group of their leaders. There were tears, hugs, laughs, and 10 lbs of pebbles that I somehow managed to get through TSA 😂 Thank you for the incredible hospitality and for trusting in me! Big thanks to my amazing partners at SpeakInc for the flawless execution teaming up on this event.
-
-
Join us Monday, June 24 for our job fair to learn more about opportunities at Iovance Cell Therapy Center in the Navy Yard Philadelphia! Open roles: https://lnkd.in/gDy--h3i #philadelphiajobs #phillyjobs #biotechjobs
We're hiring! To learn more about open positions at the Iovance Cell Therapy Center in the Philadelphia Navy Yard, attend our job fair on Monday, June 24. View current open positions here: https://lnkd.in/gDy--h3i
This content isn’t available here
Access this content and more in the LinkedIn app
-
Interested in learning more about career opportunities at Iovance in Philadelphia? Please join us on June 24 for our Iovance Cell Therapy Center Job Fair to learn more and meet members of our team. #philadelphiajobs #phillyjobs #philadelphiacareers #phillycareers #celltherapycareers
We're hiring! To learn more about open positions at the Iovance Cell Therapy Center in the Philadelphia Navy Yard, attend our job fair on Monday, June 24. View current open positions here: https://lnkd.in/gDy--h3i
This content isn’t available here
Access this content and more in the LinkedIn app
-
Iovance Biotherapeutics, Inc. reposted this
📢 Tomorrow (June 4) is the last day to apply for The Wistar Institute's award-winning Biomedical Technician Training Program! Those with a high school diploma or equivalent and an interest in the life sciences are encouraged to apply. Upon successful completion of the training program, applicants will have an opportunity to interview for open positions with Iovance Biotherapeutics, Inc. or Integral Molecular with roles starting at $21/hour. More information below ⬇
The Wistar Institute’s award-winning Biomedical Technician Training (BTT) Program has begun another recruitment effort for Philadelphians looking to participate in our region’s thriving life science economy. “In this fifth cohort of our BTT Program with the West Philadelphia Skills Initiative , we are excited to train Philadelphia residents for job opportunities with Integral Molecular and Iovance Biotherapeutics, Inc. - two employers fueling the life science sector here in Philadelphia,” said Dr. Kristy Shuda McGuire, Dean of Biomedical Studies in the Hubert J.P. Schoemaker Education and Training Center at The Wistar Institute. Read our story about this collaboration between Wistar, WPSI, Integral Molecular, Iovance Biotherapeutics, PIDC, and The Chamber of Commerce for Greater Philadelphia here: https://bit.ly/4bPeawh #training #phillylifesciences #opportunity #philly
Award-Winning Biotech Program Begins Another Recruitment to Connect Philadelphians with Quality Jobs in the Region’s Rapidly Growing Life Science Sector
https://www.wistar.org
-
Iovance Biotherapeutics, Inc. reposted this
The Wistar Institute’s award-winning Biomedical Technician Training (BTT) Program has begun another recruitment effort for Philadelphians looking to participate in our region’s thriving life science economy. “In this fifth cohort of our BTT Program with the West Philadelphia Skills Initiative , we are excited to train Philadelphia residents for job opportunities with Integral Molecular and Iovance Biotherapeutics, Inc. - two employers fueling the life science sector here in Philadelphia,” said Dr. Kristy Shuda McGuire, Dean of Biomedical Studies in the Hubert J.P. Schoemaker Education and Training Center at The Wistar Institute. Read our story about this collaboration between Wistar, WPSI, Integral Molecular, Iovance Biotherapeutics, PIDC, and The Chamber of Commerce for Greater Philadelphia here: https://bit.ly/4bPeawh #training #phillylifesciences #opportunity #philly
Award-Winning Biotech Program Begins Another Recruitment to Connect Philadelphians with Quality Jobs in the Region’s Rapidly Growing Life Science Sector
https://www.wistar.org
-
Check out the progress within our immuno-oncology pipeline and clinical trials in solid tumors at #ASCO24. Visit us booth #19149! Learn more: https://lnkd.in/e4mk3QX2
-
Today we announced updated clinical data in frontline advanced melanoma will be presented at #ASCO24: https://lnkd.in/e4mk3QX2
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting | IOVANCE Biotherapeutics, Inc.
ir.iovance.com
-
Iovance Biotherapeutics, Inc. reposted this
We are excited to announce our first multi-employer cohort to prepare graduates for Research Technician or Aseptic Manufacturing Technician roles! Learn more at navyyard.org/skills. Built in collaboration with The Wistar Institute and employer partners Iovance Biotherapeutics, Inc. and Integral Molecular, this project is made possible with support from PIDC's Navy Yard Philadelphia, The Chamber of Commerce for Greater Philadelphia, University City Science Center, Philadelphia Works, Inc., and Wexford Science & Technology, LLC.
-
Ähnliche Seiten
Jobs durchsuchen
Finanzierung
Iovance Biotherapeutics, Inc.
8 total rounds
Siehe mehr Informationen auf crunchbase
Letzte Runde
Eigenkapital nach dem IPO
Externer Crunchbase Link für die letzte Finanzierungsrunde
US$ 211.0M